Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria

NCT06795373 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor terminated study

Conditions

Chronic Spontaneous Urticaria
CSU

Interventions

DRUG: Ritlecitinib

Sponsor

Ahuva D Cices